#escmid
LightNews LightNews
krutikakuppalli.bsky.social
As the Ebola outbreak in DRC continues, understanding the evidence around BDBV vaccines remains critical.

Tomorrow, Dr Maheshi Ramasamy; chair of the @escmid.bsky.social Vaccine Subcommittee will bring together experts to discuss work on BDBV vaccines

Register 👇
us06web.zoom.us/webinar/regi...
Welcome! You are invited to join a webinar: The BDBV vaccine development pipeline: from early development to phase 2/3 evaluation. After registering, you will receive a confirmation email about joinin...
This webinar was prepared by the ESCMID Vaccines Subcommittee in collaboration with the ESCMID Emerging Infections Subcommittee. Chairs: Maheshi Ramasamy (ESCMID Vaccines Subcommittee) & Marta Mora-...
us06web.zoom.us
September 30, 2026 at 4:24 AM
dfisman.bsky.social
More good news on the airborne front: actually got invited to talk about aerosols and infection at an upcoming ESCMID hospital infections course. There’s a hunger for this knowledge in some quarters…if we can teach people, we can make change.
February 10, 2024 at 2:19 PM
drandrealove.bsky.social
It’s official!

I’m headed to Vienna to speak at ESCMID in April. 🦠

Aside from driving through on my way from Berlin to Bormio, this’ll be my first trip to Austria.

Where my fellow infectious disease folks at 👀
January 11, 2025 at 1:10 AM
absteward.bsky.social
🔥Just published 🔥
ESCMID Clinical Guidelines on the Evaluation and Management of a Reported Antibiotic Allergy #IDSjy
www.clinicalmicrobiologyandinfection.org/article/S119...
February 16, 2026 at 2:12 PM
gurujosh.bsky.social
#SNAPtrial will answer this question in a large RCT (rather than observational). Come to ESCMID global and hear the results!
February 13, 2025 at 8:20 PM
steventong.bsky.social
ESCMID 2026 highlights

COBRA Trial – One day is enough

Dutch RCT: 1 day of antibiotics after ERCP drainage for cholangitis was non‑inferior to 4–7 days.

Bottom line: Antibiotic durations can safely be much shorter once source control is achieved.

#IDSky

clarityinitiative.org/escmid-2026-...
Clarity Initiative
Clinical Literature Appraisal and Research education in InfecTious diseases
clarityinitiative.org
May 14, 2026 at 11:37 AM
escmid.bsky.social
ESCMID strongly believes in the importance of unbiased scientific research and discussions amongst the global community. The ESCMID Executive Committee released a commentary on the recent political decisions made in the US.
www.clinicalmicrobiologyandinfection.com/article/S119...
#IDSky #Clinmicro
March 18, 2025 at 1:07 PM
eaccme.bsky.social
EACCME accredited✅

European Society of Clinical Microbiology and Infectious Diseases (ESCMID)

#uems
#eaccme
#MedicalMicrobiology
#liveevent
September 30, 2026 at 8:24 AM
angelahuttner.bsky.social
Just published: ESCMID's statement on US policy changes

Thank you @escmid.bsky.social for speaking out on this 🌏

#IDSky #Clinmicro #MicroSky #MedSky #EpiSky #vaccines #AMR #publichealth #standupforscience

www.cmi-comms.com/article/S295...
Global impact of US policy changes; the ESCMID perspective
The European Society of Clinical Microbiology and Infectious Diseases (ESCMID) strongly believes in the importance of unbiased scientific research and full, open and honest discussions amongst the glo...
www.cmi-comms.com
March 18, 2025 at 1:44 PM
marionkoopmans.bsky.social
@escmid.bsky.social www.escmid.org/science-rese... Thanks you ESCMID! Looking forward to present at the annual meeting
Awardees Gallery
Explore the gallery of esteemed ESCMID members celebrated with grants and awards.
www.escmid.org
December 15, 2024 at 12:34 PM
escmid.bsky.social
📣ESCMID is now on Threads & BlueSky! 🧵🦋 Keep up w/ #ESCMID activities all year 🫠

Help build our ID community & follow us on our newest platforms! By doing so, you will be entered to win cool prizes at #ESCMIDGlobal 2025 & beyond. ✨ Campaign ends today!

#IDSky #clinmicro #campaign #day4 #giveaway
April 3, 2025 at 3:11 PM
steventong.bsky.social
Highlights from ESCMID Global 2026?
@gurujosh.bsky.social asked CLARITY faculty: @angelahuttner.bsky.social @erinmccreary.bsky.social @marcbonten.bsky.social @seanong.bsky.social @ashabowen.bsky.social and others (not on BlueSky).

#IDSky

clarityinitiative.org/escmid-2026-...

Any that we missed?
Clarity Initiative
Clinical Literature Appraisal and Research education in InfecTious diseases
clarityinitiative.org
May 14, 2026 at 1:04 AM
drneilstone.bsky.social
I see ESCMID spam email season is upon us
March 7, 2025 at 3:17 PM
alanmcn1.bsky.social
I know you will all play a tiny violin but I genuinely very rarely get invited to speak at big conferences. So the invite this morning to present at ESCMID next year is a career highlight! Can’t wait!!!!
July 14, 2025 at 3:00 PM
cmicomms.bsky.social
Our collaboration episode with Breakpoints covering the trials from the ESCMID Global session 'The trial run' is out now! share.transistor.fm/s/e2a9aee4 🎙️✨

@erinmccreary.bsky.social @gurujosh.bsky.social @jesusrbano.bsky.social #IDSky #clinmicro
May 8, 2026 at 11:04 AM
chantalrovers.bsky.social
Listening to @marionkoopmans.bsky.social giving the ESCMID excellence award lecture “Towards pandemic prevention, moonshot or utopia?” at #ESCMIDGlobal

@escmid.bsky.social
April 14, 2025 at 2:22 PM
contagionlive.bsky.social
IDSA and ESCMID released consensus statements to assist in managing individuals with Staphylococcus aureus and follow-up blood cultures. This review will focus on adult patients and additional information on the pediatric population.
#IDsky #Medsky
www.contagionlive.com/view/idsa-es...
IDSA/ESCMID Statement on Staphylococcus aureus: Follow-Up Blood Cultures | Contagion Live
Staphylococcus aureus Bacteremia (SAB) causes significant morbidity and globally is the leading cause of death from bloodstream infection. This month, the IDSA and ESCMID released 7 consensus statemen...
www.contagionlive.com
September 28, 2026 at 8:54 PM
escmid.bsky.social
📣ESCMID members📣 comment on the "Clinical Practice Guidelines by @idsainfo.bsky.social: 2024 Update on Diagnosis & Management of IV catheter-related infections" draft until 6 Jan 2025

Find out how on the ESCMID guidelines page "under public consultation" ow.ly/Tnj450Uu7QF

#IDSky #clinmicro
December 19, 2024 at 3:53 PM
esguti-studygroup.bsky.social
Welcome to ESGUTI on BlueSky!

We are the newly founded ESCMID Study Group for Urinary Tract Infections (UTIs) - all working together to improve UTI care through collaboration, science and innovation.

We’re just getting started - and look forward to you joining us!
#ESGUTI #ESCMID #UTI #JoinUs
June 30, 2025 at 2:23 PM
sidpharm.bsky.social
The Society of Infectious Diseases Pharmacists and ESCMID are excited to release a new Breakpoints episode:

ESCMID Global Trials: PETER PEN and ASTARTE

Check it out!
May 8, 2026 at 9:01 AM
escmid.bsky.social
We are happy to announce the ESCMID awardees for 2025 to honour their excellence and innovation in clinical microbiology and infectious diseases.

Congratulations to Marion Koopmans (@marionkoopmans.bsky.social), Arturo Casadevall and Jan Verhoef!

ow.ly/8ESg50UqtFc

#IDSky #ClinMicro #MedSky
December 19, 2024 at 8:35 AM
jennyrohn.bsky.social
Just registered for #ESCMID 2025 in Vienna, where I'll be speaking about advanced human cell-based infection models for #UTI! My first time - who else is going? @escmid.bsky.social #IDSky #UTISky
December 5, 2024 at 9:28 AM
grod11.bsky.social
Excited to be appointed as the ESCMID Local Champion for the U.S. for the next three years! After many rewarding experiences, I look forward to promoting ESCMID Global and championing infectious diseases—especially the often-overlooked field of healthcare epidemiology!
March 11, 2025 at 12:23 AM
angelahuttner.bsky.social
Anyone presenting an abstract at ESCMID Global:

If you've been approached by a journal to publish that abstract (usually for a fee), you can say no thanks. As in 2024, CMI Comms will publish all abstracts #open-access for free

#IDSky #Clinmicro #MicroSky #MedSky
www.cmi-comms.com/article/S295...
ESCMID Global Abstract Book 2024
www.cmi-comms.com
March 25, 2025 at 3:20 PM
ayaiizuka.bsky.social
ESCMID #4 😍🧫🦠
April 12, 2025 at 9:43 AM